Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Remedy Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Remedy Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 445 · Grade C

Remedy Meds

Visit Remedy Meds Full brief →

FDA warning letter, September 2025 — issued to Remedy Meds. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 55 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Remedy Meds a bad call — it's best for readers comparing the full renewal price and willing to check the next charge date before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
32
Access Breadth
93
50
Clinical Oversight
92
82
Track Record
88
51
CoreAge RxBrief Score 94 · 55Remedy Meds

Price, coverage & the tracker

CoreAge RxRemedy Meds
Brief Score94/100 (A)55/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$179 first month, then $299/mo. Listed supply is four weeks.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$279 first month, then $399/mo. Listed supply is four weeks.

CoverageUS only; restrictions by state, confirmed at intakeConfirm availability for your prescription and address.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Remedy Meds: Check the next charge date and what happens if you skip a refill.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.